• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Medicamen Organics Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting

    29-05-2026 | 07:40 pm

    Medicamen Organics' board approved FY26 consolidated results: Revenue Rs 22.63 Cr, Loss Rs 4.02 Cr. IPO funds of Rs 1.62 Cr reallocated to working capital. A subsidiary wrote off Rs 1.10 Cr receivable. Noted new Indian subsidiaries and an unconsolidated Rwandan acquisition.

    No comments yet. Be the first to comment!

    All announcements from Medicamen Organics Limited